Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

1.

Recommendations for the pharmacologic management of allergic rhinitis.

Hoyte FC, Meltzer EO, Ostrom NK, Nelson HS, Bensch GW, Spangler DL, Storms WW, Weinstein SF, Katial RK.

Allergy Asthma Proc. 2014 May-Jun;35 Suppl 1:S20-7. doi: 10.2500/aap.2014.35.3761.

PMID:
25582158
2.

Moving toward clarity in the treatment of allergic rhinitis.

Katial RK.

Allergy Asthma Proc. 2014 May-Jun;35 Suppl 1:S1-2. doi: 10.2500/aap.2014.35.3759. No abstract available.

PMID:
25582155
3.

Characterization and treatment of patients with chronic rhinosinusitis and nasal polyps.

Fountain CR, Mudd PA, Ramakrishnan VR, Sillau SH, Kingdom TT, Katial RK.

Ann Allergy Asthma Immunol. 2013 Nov;111(5):337-41. doi: 10.1016/j.anai.2013.07.017. Epub 2013 Aug 20.

PMID:
24125137
4.

Reply: To PMID 22236727.

Hoyte FC, Katial RK.

J Allergy Clin Immunol. 2013 Jan;131(1):246-7. doi: 10.1016/j.jaci.2012.09.035. Epub 2012 Nov 10. No abstract available.

PMID:
23146378
5.

Update on biomarkers in allergy and asthma. Preface.

Katial RK.

Immunol Allergy Clin North Am. 2012 Aug;32(3):ix. doi: 10.1016/j.iac.2012.06.001. Epub 2012 Jul 7. No abstract available.

PMID:
22877621
6.

Bronchoprovocation testing in asthma.

Katial RK, Covar RA.

Immunol Allergy Clin North Am. 2012 Aug;32(3):413-31. doi: 10.1016/j.iac.2012.06.002. Epub 2012 Jul 20. Review.

PMID:
22877619
7.

Exhaled nitric oxide.

Stewart L, Katial RK.

Immunol Allergy Clin North Am. 2012 Aug;32(3):347-62. doi: 10.1016/j.iac.2012.06.005. Epub 2012 Jul 5. Review.

PMID:
22877614
8.

Pancreatitis as a novel complication of aspirin therapy in patients with aspirin-exacerbated respiratory disease.

Hoyte FC, Weber RW, Katial RK.

J Allergy Clin Immunol. 2012 Jun;129(6):1684-6. doi: 10.1016/j.jaci.2011.12.003. Epub 2012 Jan 10. No abstract available.

PMID:
22236727
9.

Variations in expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in nasal mucosa of aspirin-sensitive versus aspirin-tolerant patients with nasal polyposis.

Mudd PA, Katial RK, Alam R, Hohensee S, Ramakrishnan V, Kingdom TT.

Ann Allergy Asthma Immunol. 2011 Oct;107(4):353-9. doi: 10.1016/j.anai.2011.07.016. Epub 2011 Aug 27.

10.

Antihistamine therapy in allergicĀ rhinitis.

Hoyte FC, Katial RK.

Immunol Allergy Clin North Am. 2011 Aug;31(3):509-43. doi: 10.1016/j.iac.2011.05.003.

PMID:
21737041
11.

Suggested updated approaches to patient management.

Katial RK, Meltzer EO, Lieberman P, Ratner PH, Berger WE, Kaliner MA, Siegel CJ, Bukstein DA, Ciervo CA, Marple B.

Ann Allergy Asthma Immunol. 2011 Feb;106(2 Suppl):S17-9. doi: 10.1016/j.anai.2010.10.029. No abstract available.

PMID:
21277529
12.

Intranasal antihistamines in the treatment of allergic rhinitis.

Katial RK.

Ann Allergy Asthma Immunol. 2011 Feb;106(2 Suppl):S1. doi: 10.1016/j.anai.2010.09.027. No abstract available.

PMID:
21277527
13.

Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone.

Katial RK, Bernstein D, Prazma CM, Lincourt WR, Stempel DA.

Allergy Asthma Proc. 2011 Mar-Apr;32(2):127-36. doi: 10.2500/aap.2011.32.3426. Epub 2010 Dec 28.

PMID:
21189151
14.

The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases.

Katial RK, Strand M, Prasertsuntarasai T, Leung R, Zheng W, Alam R.

J Allergy Clin Immunol. 2010 Oct;126(4):738-44. doi: 10.1016/j.jaci.2010.06.036. Epub 2010 Aug 21.

PMID:
20728206
15.

Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis.

Katial RK, Oppenheimer JJ, Ostrom NK, Mosnaim GS, Yancey SW, Waitkus-Edwards KR, Prillaman BA, Ortega HG.

Allergy Asthma Proc. 2010 Jan-Feb;31(1):68-75. doi: 10.2500/aap.2010.31.3306.

PMID:
20167147
16.

Establishing the onset of action of intranasal corticosteroids: is there an ideal study design?

Katial RK, Salapatek AM, Patel P.

Allergy Asthma Proc. 2009 Nov-Dec;30(6):595-604. doi: 10.2500/aap.2009.30.3291. Review.

PMID:
20031006
17.

IgG antibodies produced during subcutaneous allergen immunotherapy mediate inhibition of basophil activation via a mechanism involving both FcgammaRIIA and FcgammaRIIB.

Cady CT, Powell MS, Harbeck RJ, Giclas PC, Murphy JR, Katial RK, Weber RW, Hogarth PM, Johnson S, Bonvini E, Koenig S, Cambier JC.

Immunol Lett. 2010 May 4;130(1-2):57-65. doi: 10.1016/j.imlet.2009.12.001. Epub 2009 Dec 30.

18.

Safety of binodenoson, a selective adenosine A2A receptor agonist vasodilator pharmacological stress agent, in healthy subjects with mild intermittent asthma.

Murray JJ, Weiler JM, Schwartz LB, Busse WW, Katial RK, Lockey RF, McFadden ER Jr, Pixton GC, Barrett RJ.

Circ Cardiovasc Imaging. 2009 Nov;2(6):492-8. doi: 10.1161/CIRCIMAGING.108.817932. Epub 2009 Sep 17.

19.

Intranasal antihistamines for allergic rhinitis: examining the clinical impact.

Cassell HR, Katial RK.

Allergy Asthma Proc. 2009 Jul-Aug;30(4):349-57. doi: 10.2500/aap.2009.30.3261. Review.

PMID:
19772757
20.

Assessing nasal symptom control.

Erekosima NU, Katial RK.

Curr Allergy Asthma Rep. 2009 Mar;9(2):134-9. Review.

PMID:
19210903
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk